{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:28:37Z","timestamp":1793413717787,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["32401109"],"award-info":[{"award-number":["32401109"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Research Fund of Anhui Institute of Translational Medicine","award":["2023zhyx-C18"],"award-info":[{"award-number":["2023zhyx-C18"]}]},{"name":"the Research Program of Anhui Provincial Department of Education","award":["2024AH050830"],"award-info":[{"award-number":["2024AH050830"]}],"id":[{"id":"https:\/\/ror.org\/012m7k033","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the Natural Science Foundation of Jiangsu Province","award":["BK20243061"],"award-info":[{"award-number":["BK20243061"]}]},{"name":"the Key Program of National Natural Science Foundation of China","award":["82330055"],"award-info":[{"award-number":["82330055"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Mesenchymal stromal cell-derived exosomes (MEXs) possess inherent homing capabilities, tissue repair abilities, and anti-inflammatory and immunomodulatory functions, making them a promising alternative for treating lupus nephritis (LN). In this study, we present an innovative engineered MEX that serves both as a reactive oxygen species (ROS) scavenger and a rapamycin carrier for targeted LN therapy. The nanohybrid (CEX@Rapa) was developed by chemically conjugating ceria (Ce) nanoparticles to rapamycin-loaded thiol-functionalized MEXs through a Michael addition reaction. The resulting nanohybrids demonstrate minimal toxicity, optimal drug loading efficiency, superior cellular uptake capability, and remarkable anti-oxidant, anti-damage, and anti-inflammatory properties. Upon systemic administration to MRL\/lpr mice, these nanohybrids tend to accumulate and persist at the site of kidney inflammation, mitigating the excessive immune response and promoting kidney repair, leading to significant alleviation of LN symptoms through the independent and synergistic effects of MEXs, Ce nanoparticles, and rapamycin. Therefore, we believe that Ce-immobilized MEXs, as an enhanced drug nanocarrier with ROS-regulating and immunomodulatory capabilities, hold substantial promise for treating LN and other autoimmune diseases.<\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical Abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1186\/s12951-025-03731-1","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:16:17Z","timestamp":1760098577000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Engineered exosomes conferred with ROS-regulation and immuno-suppression for ameliorating lupus nephritis"],"prefix":"10.1186","volume":"23","author":[{"given":"Jiang","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zexin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhicheng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haofang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,10]]},"reference":[{"issue":"10441","key":"3731_CR1","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1016\/S0140-6736(24)00398-2","volume":"403","author":"A Hoi","year":"2024","unstructured":"Hoi A, Igel T, Mok CC, Arnaud L. Systemic lupus erythematosus. Lancet. 2024;403(10441):2326\u201338.","journal-title":"Lancet"},{"issue":"2","key":"3731_CR2","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.kint.2024.10.018","volume":"107","author":"AS De Vriese","year":"2025","unstructured":"De Vriese AS, Sethi S, Fervenza FC. Lupus nephritis: redefining the treatment goals. Kidney Int. 2025;107(2):198\u2013211.","journal-title":"Kidney Int"},{"issue":"8","key":"3731_CR3","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1038\/s41590-024-01898-7","volume":"25","author":"GC Tsokos","year":"2024","unstructured":"Tsokos GC. The immunology of systemic lupus erythematosus. Nat Immunol. 2024;25(8):1332\u201343.","journal-title":"Nat Immunol"},{"issue":"4","key":"3731_CR4","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1002\/art.42784","volume":"76","author":"J Taubmann","year":"2024","unstructured":"Taubmann J, Mueller F, Mutlu MY, Voelkl S, Aigner M, Bozec A, Mackensen A, Grieshaber-Bouyer R, Schett G. CD19 chimeric antigen receptor T cell treatment: unraveling the role of B cells in systemic lupus erythematosus. Arthritis Rheumatol. 2024;76(4):497\u2013504.","journal-title":"Arthritis Rheumatol"},{"issue":"10437","key":"3731_CR5","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/S0140-6736(24)00424-0","volume":"403","author":"T Krickau","year":"2024","unstructured":"Krickau T, Naumann-Bartsch N, Aigner M, Kharboutli S, Kretschmann S, Spoerl S, et al. Cart-cell therapy rescues adolescent with rapidly progressive lupus nephritis from haemodialysis. Lancet. 2024;403(10437):1627\u201330.","journal-title":"Lancet"},{"issue":"10126","key":"3731_CR6","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/S0140-6736(18)30485-9","volume":"391","author":"Z-W Lai","year":"2018","unstructured":"Lai Z-W, Kelly R, Winans T, Marchena I, Shadakshari A, Yu J, Dawood M, Garcia R, Tily H, Francis L, Faraone SV, Phillips PE, Perl A. Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1\/2 trial. Lancet. 2018;391(10126):1186\u201396.","journal-title":"Lancet"},{"key":"3731_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46441-2","author":"NC Huang","year":"2024","unstructured":"Huang NC, Winans T, Wyman B, Oaks Z, Faludi T, Choudhary G, et al. Rab4A-directed endosome traffic shapes pro-inflammatory mitochondrial metabolism in T cells via mitophagy, CD98 expression, and kynurenine-sensitive mTOR activation. Nat Commun. 2024. https:\/\/doi.org\/10.1038\/s41467-024-46441-2.","journal-title":"Nat Commun"},{"issue":"6","key":"3731_CR8","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/s43587-023-00416-y","volume":"3","author":"JB Mannick","year":"2023","unstructured":"Mannick JB, Lamming DW. Targeting the biology of aging with mTOR inhibitors. Nat Aging. 2023;3(6):642\u201360.","journal-title":"Nat Aging"},{"key":"3731_CR9","doi-asserted-by":"crossref","unstructured":"Schreiber KH, Apelo SIA, Yu D, Brinkman JA, Velarde MC, Syed FA, Liao C-Y, Baar EL, Carbaja KA, Sherman DS, Ortiz D, Brunauer R, Yang SE, Tzannis ST, Kennedyl BK, Lamming DW. A novel rapamycin analog is highly selective for mTORC1 in vivo. Nat Commun. 2019;10.","DOI":"10.1038\/s41467-019-11174-0"},{"issue":"3","key":"3731_CR10","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41565-021-01048-2","volume":"17","author":"JA Burke","year":"2022","unstructured":"Burke JA, Zhang X, Bobbala S, Frey MA, Fuentes CB, Haddad HF, Allen SD, Richardson RAK, Ameer GA, Scott EA. Subcutaneous nanotherapy repurposes the immunosuppressive mechanism of Rapamycin to enhance allogeneic islet graft viability. Nat Nanotechnol. 2022;17(3):319.","journal-title":"Nat Nanotechnol"},{"issue":"4","key":"3731_CR11","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41578-022-00529-7","volume":"8","author":"SA Dilliard","year":"2023","unstructured":"Dilliard SA, Siegwart DJ. Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugs. Nat Rev Mater. 2023;8(4):282\u2013300.","journal-title":"Nat Rev Mater"},{"key":"3731_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202401445","volume":"36","author":"D Song","year":"2024","unstructured":"Song D, Zhao Y, Wang Z, Xu Q. Tuning lipid nanoparticles for RNA delivery to extrahepatic organs. Adv Mater. 2024;36:44.","journal-title":"Adv Mater"},{"key":"3731_CR13","volume":"36","author":"J Han","year":"2024","unstructured":"Han J, Sheng T, Zhang Y, Cheng H, Gao J, Yu J, et al. Bioresponsive immunotherapeutic materials. Adv Mater. 2024;36:43.","journal-title":"Adv Mater"},{"key":"3731_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2023.114770","author":"H Han","year":"2023","unstructured":"Han H, Li S, Xu M, Zhong Y, Fan W, Xu J, et al. Polymer- and lipid-based nanocarriers for ocular drug delivery: current status and future perspectives. Adv Drug Deliv Rev. 2023. https:\/\/doi.org\/10.1016\/j.addr.2023.114770.","journal-title":"Adv Drug Deliv Rev"},{"key":"3731_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.128738","author":"X Li","year":"2024","unstructured":"Li X, Wang S, Zhong J, Li T, Fan G, Zhou D, et al. Preparation and characterization of fine and stable short amylose nanocarriers for curcumin using a highly efficient and convenient method. Int J Biol Macromol. 2024. https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.128738.","journal-title":"Int J Biol Macromol"},{"issue":"4","key":"3731_CR16","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.7150\/thno.22078","volume":"8","author":"JO Martinez","year":"2018","unstructured":"Martinez JO, Molinaro R, Hartman KA, Boada C, Sukhovershin R, De Rosa E, Kirui D, Zhang S, Evangelopoulos M, Carter AM, Bibb JA, Cooke JP, Tasciotti E. Biomimetic nanoparticles with enhanced affinity towards activated endothelium as versatile tools for theranostic drug delivery. Theranostics. 2018;8(4):1131\u201345.","journal-title":"Theranostics"},{"key":"3731_CR17","first-page":"206","volume":"37","author":"S Shang","year":"2024","unstructured":"Shang S, Li X, Wang H, Zhou Y, Pang K, Li P, et al. Targeted therapy of kidney disease with nanoparticle drug delivery materials. Bioact Mater. 2024;37:206\u201321.","journal-title":"Bioact Mater"},{"issue":"4","key":"3731_CR18","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41577-022-00763-8","volume":"23","author":"EI Buzas","year":"2023","unstructured":"Buzas EI. The roles of extracellular vesicles in the immune system. Nat Rev Immunol. 2023;23(4):236\u201350.","journal-title":"Nat Rev Immunol"},{"key":"3731_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2022.103260","author":"Y Fang","year":"2023","unstructured":"Fang Y, Ni J, Wang Y-S, Zhao Y, Jiang L-Q, Chen C, et al. Exosomes as biomarkers and therapeutic delivery for autoimmune diseases: opportunities and challenges. Autoimmun Rev. 2023. https:\/\/doi.org\/10.1016\/j.autrev.2022.103260.","journal-title":"Autoimmun Rev"},{"key":"3731_CR20","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau6977","volume":"367","author":"R Kalluri","year":"2020","unstructured":"Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367:6478.","journal-title":"Science"},{"issue":"9","key":"3731_CR21","doi-asserted-by":"publisher","first-page":"8530","DOI":"10.1021\/acsnano.3c00839","volume":"17","author":"D Deng","year":"2023","unstructured":"Deng D, Li X, Zhang J-J, Yin Y, Tian Y, Gan D, et al. Biotin-avidin system-based delivery enhances the therapeutic performance of MSC-derived exosomes. ACS Nano. 2023;17(9):8530\u201350.","journal-title":"ACS Nano"},{"issue":"6","key":"3731_CR22","doi-asserted-by":"publisher","first-page":"3422","DOI":"10.1021\/acs.nanolett.8b04148","volume":"19","author":"N Perets","year":"2019","unstructured":"Perets N, Betzer O, Shapira R, Brenstein S, Angel A, Sadan T, Ashery U, Popovtzer R, Offen D. Golden exosomes selectively target brain pathologies in neurodegenerative and neurodevelopmental disorders. Nano Lett. 2019;19(6):3422\u201331.","journal-title":"Nano Lett"},{"issue":"11","key":"3731_CR23","doi-asserted-by":"publisher","first-page":"5248","DOI":"10.7150\/thno.54550","volume":"11","author":"J-Y Cao","year":"2021","unstructured":"Cao J-Y, Wang B, Tang T-T, Wen Y, Li Z-L, Feng S-T, Wu M, Liu D, Yin D, Ma K-L, Tang R-N, Wu Q-L, Lan H-Y, Lv L-L, Liu B-C. Exosomal miR-125b-5p deriving from mesenchymal stem cells promotes tubular repair by suppression of p53 in ischemic acute kidney injury. Theranostics. 2021;11(11):5248\u201366.","journal-title":"Theranostics"},{"key":"3731_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01735-1","author":"MA Kumar","year":"2024","unstructured":"Kumar MA, Baba SK, Sadida HQ, Marzooqi SA, Jerobin J, Altemani FH, et al. Extracellular vesicles as tools and targets in therapy for diseases. Signal Transduct Target Ther. 2024. https:\/\/doi.org\/10.1038\/s41392-024-01735-1.","journal-title":"Signal Transduct Target Ther"},{"key":"3731_CR25","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.4c13028","author":"H Jiang","year":"2024","unstructured":"Jiang H, Zhu X, Yu J, Wang W, Mao Y, Jiang L, et al. Biomimetic extracellular vesicles based on composite bioactive ions for the treatment of ischemic bone disease. ACS Nano. 2024. https:\/\/doi.org\/10.1021\/acsnano.4c13028.","journal-title":"ACS Nano"},{"key":"3731_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-022-03174-7","author":"M Zhang","year":"2022","unstructured":"Zhang M, Johnson-Stephenson TK, Wang W, Wang Y, Li J, Li L, et al. Mesenchymal stem cell-derived exosome-educated macrophages alleviate systemic lupus erythematosus by promoting efferocytosis and recruitment of IL-17+ regulatory T cell. Stem Cell Res Ther. 2022. https:\/\/doi.org\/10.1186\/s13287-022-03174-7.","journal-title":"Stem Cell Res Ther"},{"issue":"20","key":"3731_CR27","doi-asserted-by":"publisher","first-page":"13249","DOI":"10.1021\/acsnano.4c02420","volume":"18","author":"W Ma","year":"2024","unstructured":"Ma W, Che J, Chen W, Wang D, Zhang H, Zhao Y. Dexamethasone-integrated mesenchymal stem cells for systemic lupus erythematosus treatment via multiple immunomodulatory mechanisms. ACS Nano. 2024;18(20):13249\u201365.","journal-title":"ACS Nano"},{"issue":"12","key":"3731_CR28","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1038\/s41565-023-01523-y","volume":"18","author":"S Koo","year":"2023","unstructured":"Koo S, Sohn HS, Kim TH, Yang S, Jang SY, Ye S, Choi B, Kim SH, Park KS, Shin HM, Park OK, Kim C, Kang M, Soh M, Yoo J, Kim D, Lee N, Kim B-S, Jung Y, Hyeon T. Ceria-vesicle nanohybrid therapeutic for modulation of innate and adaptive immunity in a collagen-induced arthritis model. Nat Nanotechnol. 2023;18(12):1502\u201314.","journal-title":"Nat Nanotechnol"},{"key":"3731_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202210819","author":"YG Kim","year":"2024","unstructured":"Kim YG, Lee Y, Lee N, Soh M, Kim D, Hyeon T. Ceria-based therapeutic antioxidants for biomedical applications. Adv Mater. 2024. https:\/\/doi.org\/10.1002\/adma.202210819.","journal-title":"Adv Mater"},{"issue":"8","key":"3731_CR30","doi-asserted-by":"publisher","first-page":"7645","DOI":"10.1021\/acsnano.3c00093","volume":"17","author":"F Han","year":"2023","unstructured":"Han F, Tu Z, Zhu Z, Liu D, Meng Q, Yu Q, Wang Y, Chen J, Liu T, Han F, Li B. Targeting endogenous reactive oxygen species removal and regulating regenerative microenvironment at annulus fibrosus defects promote tissue repair. ACS Nano. 2023;17(8):7645\u201361.","journal-title":"ACS Nano"},{"issue":"34","key":"3731_CR31","doi-asserted-by":"publisher","first-page":"19086","DOI":"10.1021\/jacs.3c07048","volume":"145","author":"C Liu","year":"2023","unstructured":"Liu C, Gui L, Zheng J-J, Xu Y-Q, Song B, Yi L, et al. Intrinsic strain-mediated ultrathin ceria nanoantioxidant. J Am Chem Soc. 2023;145(34):19086\u201397.","journal-title":"J Am Chem Soc"},{"issue":"3","key":"3731_CR32","doi-asserted-by":"publisher","first-page":"3206","DOI":"10.1021\/acsnano.8b08785","volume":"13","author":"J Kim","year":"2019","unstructured":"Kim J, Kim HY, Song SY, Go S-h, Sohn HS, Baik S, Soh M, Kim K, Kim D, Kim H-C, Lee N, Kim B-S, Hyeon T. Synergistic oxygen generation and reactive oxygen species scavenging by manganese Ferrite\/Ceria Co-decorated nanoparticles for rheumatoid arthritis treatment. ACS Nano. 2019;13(3):3206\u201317.","journal-title":"ACS Nano"},{"issue":"5","key":"3731_CR33","doi-asserted-by":"publisher","first-page":"4358","DOI":"10.1021\/acsnano.2c09127","volume":"17","author":"F Zhou","year":"2023","unstructured":"Zhou F, Li M, Chen M, Chen M, Chen X, Luo Z, et al. Redox homeostasis strategy for inflammatory macrophage reprogramming in rheumatoid arthritis based on ceria oxide nanozyme-complexed biopolymeric micelles. ACS Nano. 2023;17(5):4358\u201372.","journal-title":"ACS Nano"},{"key":"3731_CR34","first-page":"381","volume":"21","author":"Q Huang","year":"2023","unstructured":"Huang Q, Yang Y, Zhao T, Chen Q, Liu M, Ji S, Zhu Y, Yang Y, Zhang J, Zhao H, Nan Y, Ai K. Passively-targeted mitochondrial tungsten-based nanodots for efficient acute kidney injury treatment. Bioact Mater. 2023;21:381\u201393.","journal-title":"Bioact Mater"},{"issue":"1 Pt","key":"3731_CR35","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.bbamem.2013.09.016","volume":"1838","author":"RM Cordeiro","year":"2014","unstructured":"Cordeiro RM. Reactive oxygen species at phospholipid bilayers: distribution, mobility and permeation. Biochim Biophys Acta. 2014;1838(1 Pt):438\u201344.","journal-title":"Biochim Biophys Acta"},{"issue":"41","key":"3731_CR36","doi-asserted-by":"publisher","first-page":"10331","DOI":"10.1021\/jf3030979","volume":"60","author":"R Liang","year":"2012","unstructured":"Liang R, Liu Y, Fu LM, Ai XC, Zhang JP, Skibsted LH. Antioxidants and physical integrity of lipid bilayers under oxidative stress. J Agric Food Chem. 2012;60(41):10331\u20136.","journal-title":"J Agric Food Chem"},{"key":"3731_CR37","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.bioactmat.2024.08.030","volume":"43","author":"H Zhu","year":"2025","unstructured":"Zhu H, Huang D, Nie M, Zhao Y, Sun L. Dexamethasone loaded DNA scavenger nanogel for systemic lupus erythematosus treatment. Bioactive Mater. 2025;43:330\u20139.","journal-title":"Bioactive Mater"},{"key":"3731_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-021-02374-x","author":"W-C Tseng","year":"2021","unstructured":"Tseng W-C, Lee P-Y, Tsai M-T, Chang F-P, Chen N-J, Chien C-T, et al. Hypoxic mesenchymal stem cells ameliorate acute kidney ischemia-reperfusion injury via enhancing renal tubular autophagy. Stem Cell Res Ther. 2021. https:\/\/doi.org\/10.1186\/s13287-021-02374-x.","journal-title":"Stem Cell Res Ther"},{"key":"3731_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2022.101454","author":"H Zhu","year":"2022","unstructured":"Zhu H, Kong B, Nie M, Zhao C, Liu R, Xie Y, et al. ECM-inspired peptide dendrimer microgels with human MSCs encapsulation for systemic lupus erythematosus treatment. Nano Today. 2022. https:\/\/doi.org\/10.1016\/j.nantod.2022.101454.","journal-title":"Nano Today"},{"key":"3731_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01452-1","author":"S Chen","year":"2023","unstructured":"Chen S, Saeed AFUH, Liu Q, Jiang Q, Xu H, Xiao GG, et al. Macrophages in immunoregulation and therapeutics. Signal Transduct Target Ther. 2023. https:\/\/doi.org\/10.1038\/s41392-023-01452-1.","journal-title":"Signal Transduct Target Ther"},{"key":"3731_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-0196-7","author":"JB Kopp","year":"2020","unstructured":"Kopp JB, Anders H-J, Susztak K, Podesta MA, Remuzzi G, Hildebrandt F, et al. Podocytopathies. Nat Rev Dis Primers. 2020. https:\/\/doi.org\/10.1038\/s41572-020-0196-7.","journal-title":"Nat Rev Dis Primers"},{"key":"3731_CR42","doi-asserted-by":"crossref","unstructured":"Chiou TT-Y, Chau Y-Y, Chen J-B, Hsu H-H, Hung S-P, Lee W-C. Rapamycin attenuates PLA2R activation-mediated podocyte apoptosis via the PI3K\/AKT\/mTOR pathway. Biomed Pharmacother.\u00a02021;144.","DOI":"10.1016\/j.biopha.2021.112349"},{"issue":"5","key":"3731_CR43","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1080\/15548627.2019.1580512","volume":"15","author":"X-J Zhou","year":"2019","unstructured":"Zhou X-J, Klionsky DJ, Zhang H. Podocytes and autophagy: a potential therapeutic target in lupus nephritis. Autophagy. 2019;15(5):908\u201312.","journal-title":"Autophagy"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03731-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03731-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03731-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:16:19Z","timestamp":1760098579000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-025-03731-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,10]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3731"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03731-1","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,10]]},"assertion":[{"value":"29 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"639"}}